Gene Therapy Advances, But Hemophilia is no Easy Target – Xconomy
XconomyGene Therapy Advances, But Hemophilia is no Easy TargetXconomyOne would think Skinner would jump at the chance, then, to try gene therapy, which offers the potential for a one-time long-lasting treatment—if not an outright cure. BioMarin Pharmac… Continue reading
